10x Genomics Blog Feb 12, 2026 10x Genomics (NASDAQ:TXG) Delivers Impressive Q4 CY2025 - Yahoo Finance
10x Genomics Blog Feb 12, 2026 10x Genomics (NASDAQ:TXG) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS - MarketBeat
10x Genomics Blog Feb 12, 2026 10x Genomics (NASDAQ: TXG) narrows 2025 losses and guides to modest 2026 growth - Stock Titan
10x Genomics Blog Feb 12, 2026 10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026 - PR Newswire
FierceBiotech Feb 12, 2026 Icon shares plummet after CRO reveals accounting investigation, pulls 2025 guidance
FierceBiotech Feb 12, 2026 Lundbeck’s migraine prevention treatment sees ph. 2 success after trial’s earlier setback
Waters Feb 12, 2026 Waters Corporation Shares Fall After Q4 Results and 2026 Sales Guidance - AlphaStreet News
Waters Feb 12, 2026 Waters Corporation Shares Fall After Q4 Results and 2026 Sales Guidance - AlphaStreet News
Waters Feb 12, 2026 Waters Corporation Shares Fall After Q4 Results and 2026 Sales Guidance - AlphaStreet News